Verona Pharma plc. (VRP.L), a drug development company focused on respiratory diseases, Monday announced the appointment of David Raymond Ebsworth as Non-Executive Chairman of the Board of Directors with effect from December 1.
Ebsworth, aged 60, will succeed Clive Page, who has held the role since founding the company in 2006.
Ebsworth has been involved in successful product approvals in the US and Europe. From October 2009 to August 2014, Ebsworth served as Chief Executive Officer of Vifor Pharma, based in Zürich, the Specialty Pharma division of Galenica AG Group. He was also named as CEO of Galenica AG in 2011. Ebsworth had worked for over 19 years in Bayer AG.
During the past five years, he has held directorships at Xention Ltd, Wilex AG and Intercell AG.
In September, Verona Pharma appointed Biresh Roy as Chief Financial Officer and member of the Board of Directors.
For comments and feedback contact: editorial@rttnews.com
Business News